Ajanta Pharma consolidated net profit rises 49.18% in the September 2026 quarter

Sales rise 32.53% to Rs 1794.16 crore

Net profit of Ajanta Pharma rose 49.18% to Rs 388.14 crore in the quarter ended September 2026 as against Rs 260.19 crore during the previous quarter ended September 2025. Sales rose 32.53% to Rs 1794.16 crore in the quarter ended September 2026 as against Rs 1353.73 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1794.16	1353.73	33
OPM %	30.52	24.22	-
PBDT	582.71	383.78	52
PBT	535.15	340.81	57
NP	388.14	260.19	49

Powered by Capital Market - Live News